All times are listed in CEST (Central European Summer Time)

Displaying One Session

View
Controversy session

Are adjuvant immune checkpoint inhibitors a standard of care for operable high-risk urothelial and kidney cancer?

Date
Mon, 20.09.2021
Time
16:45 - 17:20
Location
Channel 6
Chairs
  • Arnaud Mejean (Paris, France)
Controversy session

Introduction by the chair

Speakers
  • Arnaud Mejean (Paris, France)
Lecture Time
16:45 - 16:48
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
16:45 - 17:20
Controversy session

Polling 1 (led by chair)

Speakers
  • Arnaud Mejean (Paris, France)
Lecture Time
16:48 - 16:49
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
16:45 - 17:20
Controversy session

Yes

Speakers
  • Thomas Powles (London, United Kingdom)
Lecture Time
16:49 - 16:59
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
16:45 - 17:20
Controversy session

No

Speakers
  • Michiel S. Van der Heijden (Amsterdam, Netherlands)
Lecture Time
16:59 - 17:09
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
16:45 - 17:20
Controversy session

Polling 2 (led by chair)

Speakers
  • Arnaud Mejean (Paris, France)
Lecture Time
17:09 - 17:10
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
16:45 - 17:20
Controversy session

Q&A

Speakers
  • Arnaud Mejean (Paris, France)
Lecture Time
17:10 - 17:20
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 20.09.2021
Time
16:45 - 17:20